Skip to main content
Springer Nature Link
Account
Figure 3 | Scientific Reports

Figure 3

From: Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury

Figure 3

Experimental design and cerebral blood flow during MCAO.

(A) This diagram illustrated the experimental design including tMCAO, SQ29548 administration, neurobehavioral assessments and animal sacrifice. (B) Representation of cerebral blood flow before MCAO (as a baseline), after MCAO, and reperfusion. Sham-PBS n = 8, tMCAO-SQ29548 n = 16, tMCAO-DMSO n = 16.

Back to article page